- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Andaris gets ultrasound contrast patent
Add U.K. firm Andaris to the list of companies with patents on ultrasound contrast technology. The Nottingham firm reported this month that it has received patent No. 5,741,478 from the U.S. Patent and Trademark Office for its microcapsule technology.
Add U.K. firm Andaris to the list of companies with patents on ultrasound contrast technology. The Nottingham firm reported this month that it has received patent No. 5,741,478 from the U.S. Patent and Trademark Office for its microcapsule technology. The patent applies to its Quantison and Myomap ultrasound contrast agents under development, as well as its platelet substitute, Synthocytes, Andaris said.
Emerging Perspectives on PSMA PET Radiotracers: An Interview with Kenneth J. Pienta, MD
April 24th 2024In a recent interview, Kenneth J. Pienta, M.D., discussed the impact of piflufolastat F18, current directions in research with other PSMA-targeted radiotracers and future possibilities for the role of PSMA PET in the imaging paradigm for prostate cancer.
Could a Newly FDA-Cleared C-Arm Device Bolster Efficiency for Interventional Radiologists?
April 22nd 2024In addition to advanced imaging quality and dose efficiency, the Philips Zenition 30 mobile C-arm device emphasizes personalized user profiles and automated customization to help reduce procedure time.
